Blog
Potential COVID-19 Vaccine Shows Promise When Tested On Mice
As researchers around the world are relentlessly working to develop potential treatments and vaccines against COVID-19, an initial test of a potential vaccine conducted on mice has shown a sliver of hope.
When delivered via a fingertip-sized patch, the vaccine has shown it can induce an immune response against the coronavirus at levels that might prevent infection, as reported by the Intramural Research Program (IRP) at the National Institutes of Health (NIH).
The vaccine test is funded by the NIH, who reports scientists with the University of Pittsburgh School of Medicine are targeting the spike protein that attacks cells. When the protein attacks the cells, it creates the infection and the body develops antibodies to fight the infection.
So far, vaccinated mice are showing a trend that could lead to them creating enough antibodies to neutralize the virus for at least a year.
The scientists have started the process of receiving approval from the USDA for a Phase-1 Human Trial in the next several months.
When delivered via a fingertip-sized patch, the vaccine has shown it can induce an immune response against the coronavirus at levels that might prevent infection, as reported by the Intramural Research Program (IRP) at the National Institutes of Health (NIH).
https://t.co/tlwAcJKUnE via @skynewsarabia
— Larissa Aoun (@LarissaAounSky) April 15, 2020
The vaccine test is funded by the NIH, who reports scientists with the University of Pittsburgh School of Medicine are targeting the spike protein that attacks cells. When the protein attacks the cells, it creates the infection and the body develops antibodies to fight the infection.
So far, vaccinated mice are showing a trend that could lead to them creating enough antibodies to neutralize the virus for at least a year.
The scientists have started the process of receiving approval from the USDA for a Phase-1 Human Trial in the next several months.